Andrew H. Miller
behavioralimmunology.com
0000-0001-8260-7997
12 papers found
Refreshing results…
Simultaneous separation and detection of nine kynurenine pathway metabolites by reversed-phase liquid chromatography-mass spectrometry: Quantitation of inflammation in human cerebrospinal fluid and plasma
Psychedelics and ketamine are a symptom of psychiatry’s woes, not a cure
New and emerging approaches to treat psychiatric disorders
Burning down the house: reinventing drug discovery in psychiatry for the development of targeted therapies
Correction to: Functional connectivity in reward circuitry and symptoms of anhedonia as therapeutic targets in depression with high inflammation: evidence from a dopamine challenge study
Functional connectivity in reward circuitry and symptoms of anhedonia as therapeutic targets in depression with high inflammation: evidence from a dopamine challenge study
Cellular and immunometabolic mechanisms of inflammation in depression: Preliminary findings from single cell RNA sequencing and a tribute to Bruce McEwen
A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials
The interaction of lipids and inflammatory markers predict negative symptom severity in patients with schizophrenia
Transcriptomic signatures of psychomotor slowing in peripheral blood of depressed patients: evidence for immunometabolic reprogramming
Kynurenines increase MRS metabolites in basal ganglia and decrease resting-state connectivity in frontostriatal reward circuitry in depression
Capillary electrochromatography-mass spectrometry of kynurenine pathway metabolites
Missing publications? Search for publications with a matching author name.